Expert Interview
Delving into the data from the Phase 2b SunRISe-1 study, evaluating TAR-200 in high-risk non-muscle-invasive bladder cancer (HR-NMIBC) patients.
Ticker(s): JNJInstitution: UT Southwestern
- Chair in Urology at UT Southwestern.
- Currently manages 450 patients with prostate cancer and 120 patients with testicular cancer
- Research focuses on metastatic progression and resistance to targeted therapies and Molecular biology involved in renal cell cancer tumorigenesis.
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
